Track Medtech Start-ups

Learn More
innovation hub

Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) is Profiled in this Database

Updated At 07 Dec, 2009

Start Free 7 Day Trial Now
Partial description of this company
Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) plus 4714 other start-ups.

Start Free 7 Day Trial Now

Learn More About Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Technology/product details

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
5-mckinsey.jpg
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png